TH103 showed mean 10-letter gain in visual acuity and rapid, robust anatomic improvement at Month 1, following a single injection ...
Collaboration between specialists is essential to optimize outcomes and explore regenerative approaches for effective ...
Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.
The quickly-binding biologic lonigutamab demonstrated initial success in improving signs and symptoms of thyroid eye disease ...
The biotech’s lead asset, AVD-104, failed to beat Astellas’ Izervay at slowing the rate of retina lesion growth, the primary ...
Aviceda Therapeutics has released topline results from its phase 2b study, SIGLEC, evaluating AVD-104 in patients with ...
West Bengal mirrors the national crisis but with sharper disparities between urban and rural regions. In a large, multi-district study screening 1,553 diabetics across 14 districts, DR prevalence was ...
Early panretinal photocoagulation plus anti-VEGF for macular edema secondary to retinal vein occlusion offers no benefit over anti-VEGF alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback